期刊文献+

广州市阿尔茨海默病人及正常老人丁酰胆碱酯酶基因K变异对照研究

A control study of butyrylcholinesterase K variant in subjects with late onset Alzheimers disease and normal elderly in a Guzngzhou population
下载PDF
导出
摘要 目的 观察丁酰胆碱酯酶基因 (BCHE)K变异在广州地区汉族老年人中的分布 ,探讨其与晚发阿尔茨海默病 (AD)的关联性。方法 以 10 6例晚发AD患者和 133名健康老年人为对象进行病例 对照研究。采用等位基因特异聚合酶链反应法 (AS PCR)分析BCHE基因K型多态性。结果 晚发AD患者和正常老年人中 ,正常等位基因 1的频率分别为 93 4 0 %和 93 6 1% ,K变异等位基因 2的频率分别为 6 6 0 %和 6 39% ;晚发AD患者和正常老年人之间BCHE基因K多态各等位基因和基因型分布差异无显著性 (P >0 0 5 ) ;样本采用载脂蛋白Eε4基因 (APOEε4 )分层后 ,AD组与对照组BCHE基因K变异频率仍然无显著性差异 (P >0 0 5 )。结论 BEHE K变异在广州地区汉族人群中与晚发AD不存在关联 ,提示该多态性不是晚发AD的风险因子。 Objective To investigate the possible involvement of the butyrylcholinesterase (BCHE) K variant in the manifestation of late onset Alzheimers disease (LOAD) in the Han Chinese in Guangzhou. Methods The K variant in the BCHE gene of 106 patients with LOAD and 133 age matched normal elderly controls were examined by allele specific single step polymerase chain reaction amplification technique. Results The frequency of BCHE 1 of the two groups was 93.40% and 93.61%, respectively ( P>0.05 ). The frequency of the BCHE K in LOAD and controls was almost identical, which was 6 60% and 6 39%, respectively ( P >0 05). The occurrence of the APOE epsilon4 did not influence the distribution of the BCHE K. Conclusions Our findings indicated no association between BCHE K variant and LOAD. The BCHE K variant does not confer a risk for LOAD.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2003年第2期114-116,共3页 Chinese Journal of Nervous and Mental Diseases
基金 广州医学院科研基金资助项目 (编号 :2 0 0 0 GK 2 5 )
关键词 广州市 阿尔茨海默病 丁酰胆碱酯酶 载脂蛋白E 关联 Alzheimers disease Butyrylcholinesterase Apolipoprotein E Association
  • 相关文献

参考文献13

  • 1[1]Gomez-Ramos, P, Moran MA. Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients. Mol Chem Neuropathol, 1997, 30(3):161.
  • 2[2]Guillozet AL, Smiley JF, Mash DC, et al. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol, 1997, 42(6):909.
  • 3[3]Rubinstein HM, Dietz A, Lubrano T. E1K, another quantitave variant at cholisterase locu 1. J Med Genet, 1978, 15(1):27.
  • 4[4]Lehmann DJ, Johnston C, Smith AD. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E3 in late-onset confirmed Alzheimer's disease. Hum Mol G enet, 1997, 6(11):1933.
  • 5[5]Wiebusch H, Poirier J, Sevigny P, et al. Further evidence for a synergistic association between APOE ε4 and BCHE-K in confirmed Alzheimer's disease. Hum Genet, 1999, 104(2):158.
  • 6[6]Mcllroy SP, Crawford VL, Dynan KB, et al. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland J Med Genet, 2000, 37(3):182.
  • 7[7]Singleton AB, Smith G, Gibson AM, et al. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet, 1998, 7(5):937.
  • 8[8]Yamamoto Y, Yasuda M, Mori E, et al. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the ε4allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry, 1999, 67(1):94.
  • 9[9]Lee DW, Liu HC, Lee JH, et al. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese. Am J Med Genet, 2000, 96(2): 167.
  • 10[10]Kim KW, Jhoo JH, Lee JH, et al. Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans. J Neural Transm. 2001,108(10):1159.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部